COCP

0.95002.05%
SD

Steven D. Rubin

Independent Director

Mr. Steven D. Rubin, J.D., Esq., also known as Steve, is an Independent Director of Entera Bio Ltd. from February 1, 2026. He is Vice Chairman at Cocrystal Pharma, Inc. He has been the Independent Chairman of Neovasc Inc. since June 2018 and has been its Independent Director since July 1, 2008. He has been Strategic Advisor at usell.com, Inc. since October 18, 2013. Mr. Rubin has been an Executive Vice President of Administration at OPKO Health, Inc. since May 2007 and has been its Director since February 2007. He had been an Advisor of MabVax Therapeutics Holdings, Inc. He served as a Senior Vice President, General Counsel and Secretary of IVAX Corp. (also known as IVAX LLC) from August 2001 to September 2006. He has extensive experience as a Practicing Lawyer, General Counsel and Board Member to multiple public companies. He served as a Senior Vice President and General Counsel of Telergy, Inc. from January 2000 to August 2001 and its Secretary from April 2000 to August 2001. He served as Secretary of Ideation Acquisition Corp. from June 1, 2007 to October 2009. He was with the Miami law firm of Stearns Weaver Miller Weissler Alhadeff & Sitterson from 1986 to 2000, in the Corporate and Securities Department. He served as the Chairman of VBI Vaccines, Inc. since July 9, 2015 and served as its Independent Director from October 2012 to October 18, 2018. He is also a Member of Frost Group, LLC. He was a Director of Bio-Reference Laboratories Inc. since August 20, 2015 until 2018. Mr. Rubin has been a Director of Opko Corporation since April 2007 and IDI, Inc. since October 30, 2009. He serves as a Director of Cardo Medical, Inc. and Cocrystal Discovery, Inc. He serves as a Member of the Supervisory Board of IVAX Pharmaceuticals s.r.o. He has been a Member of Supervisory Board at interclick, inc. since July 2009. He serves as an Independent Director of IDI Holdings, LLC. He serves as a Member of Supervisory Board at Teva Czech Industries s.r.o. He joined as an Independent Director of Eloxx Pharmaceuticals, Inc. from May 2014. He has been an Independent Director of Niagen Bioscience, Inc. (formerly known as ChromaDex Corporation) since March 27, 2017 and serves as its Lead Independent Director since June 16, 2022. He has been a Director of Cocrystal Pharma, Inc. since January 2, 2014. He served as an Independent Director at Castle Brands Inc. since January 2009 until October 9, 2019. He has been Independent Director of Red Violet, Inc. since March 2018. He had been a Director of Non-Invasive Monitoring Systems Inc. since October 3, 2008 until March 13, 2023, has been Director at Kidville, Inc. since November 2007, OPKO Biologics since March 2008 and Independent Director of Sevion Therapeutics, Inc. (alternate name Senesco Technologies Inc) since May 2014. He serves as a Director of BioCardia, Inc. He has been a Board Observer at Arno Therapeutics, Inc. since November 18, 2013. Mr. Rubin served as a Director of Tiger Media, Inc. since October 30, 2009. He served as Director of Tiger X Medical, Inc. (formerly, CardoMedical, Inc.) since September 2008. He served as a Director of TransEnterix, Inc. (formerly, SafeStitch Medical, Inc.) since September 5, 2007. He served as a Director of Longfoot Communications Corp. since November 2007, Ideation Acquisition Corp., from June 01, 2007 to December 2008 and eXegenics Inc. since February 9, 2007. He served as a Director at Medical Ventures Corp. He served as a Member of Supervisory Board of Teva Kutno S.A since February 2005. He served as a Director of Dreams Inc., since November 15, 2006 and PROLOR Biotech, Inc. He served as a Director of Stearns Weaver Miller Weissler Alhadeff & Sitterson, P.A. from 1998 to 2000. Mr. Rubin served as a Director of Cogint, Inc. since October 2009 until March 12, 2018. He holds a J.D. degree from the University of Florida and obtained the title of Doctor of Laws at the Florida University in 1986. He holds a B.A. degree in Economics at the Tulane University in 1978. He was Director at Variation Biotechnologies (US), Inc. till October 18, 2018. He served as a Member of Strategic Advisory Board of Drone Aviation Holding Corp.

Positions